Kevin J. Bielamowicz

Hematology | Oncology

1 Childrens Way
Little Rock, AR 72202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.

A Phase I Study of Carfilzomib with Cyclophosphamide and Etoposide in Relapsed and Refractory Leukemia and Solid Tumors.

Journal: Cancers

Published: July 31, 2025

Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance.

Targeted Inhibition in Pediatric MET and ALK-Altered Hemispheric Gliomas: Objective Responses Followed by Treatment Resistance.

Journal: International journal of molecular sciences

Published: July 31, 2025

Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study.

Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm Study.

Journal: Targeted oncology

Published: July 04, 2025

Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma.

Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma.

Journal: Cancers

Published: April 18, 2025

Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist.

Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist.

Journal: American journal of clinical pathology

Published: January 23, 2025

A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case.

A rare presentation of pediatric germinoma mimicking optic pathway glioma: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: December 03, 2024

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 08, 2024

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.

A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function.

Journal: Cancer research communications

Published: February 28, 2024

Isolated eyelid neonatal Langerhans cell histiocytosis.

Isolated eyelid neonatal Langerhans cell histiocytosis.

Journal: Orbit (Amsterdam, Netherlands)

Published: January 30, 2024

Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.

Central nervous system embryonal tumors with EWSR1-PLAGL1 rearrangements reclassified as INI-1 deficient tumors at relapse.

Journal: Journal of neuro-oncology

Published: January 30, 2024

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Journal: Cancer

Published: January 16, 2024

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 07, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026